DexTech Medical AB

FRA:LQ0 (Sweden)  
€ 0.33 (0%) Dec 20
At Loss
P/B:
2.69
Market Cap:
€ 6.65M ($ 6.93M)
Enterprise V:
€ 5.08M ($ 5.30M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
DexTech Medical AB develops candidate medications with applications within urological oncology, for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases. The company has a well built clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.98
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.67
9-Day RSI 41.46
14-Day RSI 44.15
6-1 Month Momentum % -4.73
12-1 Month Momentum % -1.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 27.05
Quick Ratio 27.05
Cash Ratio 26.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.6
Name Current Vs Industry Vs History
ROE % -15.92
ROA % -15.52
ROIC % -51.38
ROCE % -18.6

Financials (Next Earnings Date:2025-02-27)

FRA:LQ0's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

DexTech Medical AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.023
Beta 0
Volatility % 69.52
14-Day RSI 44.15
14-Day ATR (€) 0.016998
20-Day SMA (€) 0.3393
12-1 Month Momentum % -1.83
52-Week Range (€) 0.286 - 0.602
Shares Outstanding (Mil) 18.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

DexTech Medical AB Filings

Filing Date Document Date Form
No Filing Data

DexTech Medical AB Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

DexTech Medical AB Frequently Asked Questions

What is DexTech Medical AB(FRA:LQ0)'s stock price today?
The current price of FRA:LQ0 is €0.33. The 52 week high of FRA:LQ0 is €0.60 and 52 week low is €0.29.
When is next earnings date of DexTech Medical AB(FRA:LQ0)?
The next earnings date of DexTech Medical AB(FRA:LQ0) is 2025-02-27.
Does DexTech Medical AB(FRA:LQ0) pay dividends? If so, how much?
DexTech Medical AB(FRA:LQ0) does not pay dividend.

Press Release

Subject Date
No Press Release